Form 4: Ironwood Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

An Ironwood Pharmaceuticals executive sold 11,001 shares of Class A Common Stock to cover tax obligations related to vesting restricted stock units.

Summary

• Sravan Kumar Emany, SVP, COO and CFO of Ironwood Pharmaceuticals, sold 11,001 shares of Class A Common Stock on November 18, 2024.
• The sale was executed at a price of $4.08 per share.
• This transaction was not a discretionary trade but rather an automatic sale to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Mr. Emany directly owns 309,572 shares of Ironwood Pharmaceuticals stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction related to executive compensation and tax obligations, which is common in publicly traded companies. It does not indicate any change in the company's performance or outlook.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across publicly traded companies.
• The sale of 11,001 shares is not unusual for an executive at this level.
• The price of $4.08 per share is consistent with the market price at the time of the transaction.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but this transaction is not expected to have a significant impact on shareholders.
• The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Ironwood Pharmaceuticals, Sravan Kumar Emany, stock sale, Form 4, insider trading, tax obligations, restricted stock units